Medical practice deal sourcing firms, ranked.

The medical practice deal sourcing firms worth a shortlist in 2026 are serving the single hardest sector in our own data. Across 11,236 emails to medical practice owners in our owner response rates by sector research, only 0.2 owners per 1,000 said they were open to a conversation, the lowest of the twelve sectors we measure, below diagnostic imaging at 0.5 and every other healthcare category we track. It took 5,618 emails, on average, to produce one owner willing to talk. Of the five generalist firms we checked, only one, SourceCo, names medical practices anywhere on its own live site, read on 7 November 2026 and linked as the source below. We publish this list and DealSource Systems is our own service, so it is ranked first; the other five are ranked on fit, and every claim about them is quoted from that firm's own live website in this same run.

A buyer with a physician practice thesis, whether a platform running a roll-up, a PE fund underwriting a new group, or an advisor running sell-side mandate origination for a practice owner weighing a sale, is choosing between firms that treat the sector as one line in a broad buy box, and one that has quietly built a matching product around it. Our own healthcare sell-side mandates research is the fullest public look at what a healthcare bank should expect from this specific sub-sector before it commits a programme to it.

Which medical practice deal sourcing firms actually specialise in the sector?

Only SourceCo. Its site lists "medical practices" directly among its served industries, alongside law firms, insurance agencies and veterinary practices, on sourcecodeals.com, read on 7 November 2026. The other four generalists, Harvey & Company, CapTarget, TruSight and Konverrt, make no claim naming medical or physician practices anywhere on their own sites. That gap matters more here than in most verticals we have checked, because a provider that has actually built list and messaging infrastructure for the hardest sector in our dataset starts from a real advantage, not a marketing claim.

Quick comparison

How we chose this list

We built this medical practice deal sourcing firms list by only considering firms that run owner outreach for buy-side mandates, not directories that hand over a list and leave the calling to the buyer. Every firm below states, on its own site, that it works buy-side origination for private equity, independent sponsors, family offices, search funds or M&A advisors, and we checked each specifically for whether medical or physician practices appear as a named focus. None were current DealSource Systems clients or partners at the time of writing.

DealSource Systems

Best for: a physician practice platform running roll-up acquisitions, or an M&A advisor running a sell-side mandate for a practice group considering a sale.

DealSource Systems is the origination arm of Danish Lead Co. AI maps the market and scores readiness signals, and an operator with real deal experience reviews every message before an owner sees it, described on how it works. Pricing starts from $4,000 a month for a single thesis, no success fee, 90-day minimum, published in full. Our healthcare sell-side mandates research is the proof point here: the fullest public breakdown of what a medical practice conversation actually costs to produce.

Harvey & Company

Best for: well-capitalised funds and corporations running buy-and-build at enterprise scale, where broad generalist coverage matters more than a stated medical practice record.

Harvey & Company is a buy-side acquisition search and advisory firm headquartered in Newport Beach, California. Its site lists more than 30 served sectors, including Healthcare Services and Medical Products, but no claim naming medical or physician practices appears on harveyllc.com, read on 7 November 2026, and pricing is not published. DealSource Systems vs Harvey & Company sets that scale against a thesis-driven model.

CapTarget

Best for: funds and advisors wanting volume outreach across a stated buyer base, where a medical practice thesis is one of many buy boxes rather than a named focus.

CapTarget runs off-market owner outreach for a stated "Private equity, Corporate development, Family offices, Independent sponsors, Search funds, Buy-side advisors" client base, headquartered in San Diego, and currently promotes a free "20 Free Acquisition Targets" offer. No medical or physician practice claim appears on captarget.com, read on 7 November 2026, and pricing beyond the free offer is not published. DealSource Systems vs CapTarget weighs that model against a flat retainer.

SourceCo

Best for: a buyer or advisor that wants a matching platform already built to cover medical practices, rather than a generalist that merely allows it.

SourceCo is the one firm in this list that names medical practices directly: its footer lists "medical practices" among served industries, alongside law firms, insurance agencies and veterinary practices, on sourcecodeals.com, read on 7 November 2026. It matches founder-led businesses in the "$2 million to $200 million" range with private equity, corporate development, search fund and family office buyers, and sellers pay nothing. Headquarters is not published, and buyer pricing is not disclosed on the public site. DealSource Systems vs SourceCo compares that matching model against an operator-run outreach programme.

TruSight

Best for: funds and family offices wanting a steady subscription feed of proprietary opportunities without committing to one sector thesis.

TruSight offers a retained buy-side search, intermediary coverage through "13,000+ intermediary contacts," and access to its Private Equity Info data platform, on trusightllc.com, read on 7 November 2026. No headquarters, no named sectors and no medical practice claim appear on the site, and pricing is not published. DealSource Systems vs TruSight sets that sector-agnostic feed against a defined thesis.

Konverrt

Best for: a sell-side advisor or a lower middle market buyer testing a medical practice thesis before committing to a retainer.

Konverrt serves sell-side M&A advisors pursuing owners of businesses between $2 million and $50 million first, ahead of private equity, independent sponsors and search funds, on konverrt.com. Pricing, verified live on its pricing page on 7 November 2026, is $350 to $700 per qualified owner, prepaid in batches of ten, with no retainer and no setup fee. No medical or physician practice claim appears on the site. DealSource Systems vs Konverrt is the closest read, since it sells on a similarly transparent published rate.

Why are medical practice owners so hard to reach?

Because the sector has been worked harder, for longer, than almost any other category we measure, and the owner is rarely the first person who sees the message. Across the 11,236 emails in our dataset, only 6% of human replies were open to a conversation, against 16% across all of healthcare and 42% in health tech, and 19% of replies asked not to be contacted again. Physician practice consolidation through practice management groups and private equity platforms has been running for well over a decade, so a practice worth approaching has very probably already heard from a buyer this year. The sample is small, 31 human replies from 11,236 emails, so read the exact rate as "very low" rather than precise, but the direction matches our diagnostic imaging and medical spa data, the next two hardest sub-sectors in the same dataset.

How many emails does a medical practice conversation take?

About 5,618, against 1,075 across all of healthcare and 840 across all twelve sectors we track. Put as a monthly plan, ten open owner conversations a month in medical practices needs roughly 56,000 emails, a volume that strains a single sending set-up and starts to look like the wrong channel on its own. The same ten conversations in health tech, the most open sector in our data, needs about 2,050. The owner outreach calculator runs this math against any sector if you want your own thesis priced against it before you commit a budget.

An open owner is a conversation, not a signed deal or engagement letter. Whichever side of the table you sit on, the pitch still has to be won against whoever else the owner now calls, a distinction our sell-side vs buy-side origination piece covers in more depth.

How should a buyer evaluate a medical practice deal sourcing firm?

Cold outreach alone will not fill a medical practice pipeline on a reasonable budget at this response rate, so the right evaluation starts with how a firm handles that, not with sector claims nobody here can back up.

1. 1. Ask directly whether the firm has run a medical practice mandate, and ask for the number of real owner conversations it produced, not activity volume. Only SourceCo names the sector on its own site, so a reference request is the only way to separate real experience from a buy box that happens to include healthcare.
2. 2. Price the volume against the sector's own rate. At 5,618 emails per open owner, a realistic monthly target needs tens of thousands of emails for a handful of conversations, numbers worth checking against before signing a retainer.
3. 3. Push on contact data quality. A firm that cannot explain how it reaches the practice owner directly, rather than an office manager or a shared front-desk inbox, will produce replies that never convert.
4. 4. Decide whether you are buying or selling. The firms above run buy-side outreach; a practice group going to market usually needs sell-side mandate origination run as a managed process, covered in our M&A mandate origination playbook.
5. 5. Plan for a longer nurture, not a quarterly review. Our deal origination nurture playbook sets out how to keep a not-ready practice owner warm over the months a thesis like this one usually takes, and pairing outreach with referral relationships, rather than relying on it alone, is what makes the volume problem manageable. Buyers who group medical practices with better-performing specialties on the same buy box should see how response varies first, in our optometry, ophthalmology, dermatology and pharmacy sourcing guides.

Where does DealSource Systems fit?

DealSource Systems runs origination for buyers and advisors building a medical practice thesis, including the sell-side mandates healthcare banks win from practice owners: owner-level lists, the written approach, sending infrastructure, reply handling and qualification, measured by the conversations it opens. It is priced at a flat $4,000 a month for a single defined thesis, with a 90-day minimum and no success fee, and the full pricing is published. At 5,618 emails per open owner, medical practices is one of the more expensive sectors to work the arithmetic in sell-side mandate economics. The other deal sourcing firms that work with M&A advisors are compared on fee model and fit, and our healthcare deal sourcing firms roundup covers the sector more broadly.

Conclusion

Medical practice deal sourcing firms are competing for the hardest sector we measure, and most of them do not say so. Medical practice owners answered at 0.2 per 1,000 emails, the lowest of twelve sectors in our own data, and it took 5,618 emails on average to produce one willing to talk. Only SourceCo names the sector directly among the five generalists we checked; the rest cover it as one line inside a broad healthcare buy box. A buyer or advisor with a physician practice thesis should price the volume honestly, push harder on contact data quality than on sector claims, and plan for a nurture horizon measured in months rather than weeks. If you want that arithmetic run against your own thesis, book a call.

If you would rather have this run for you, DealSource Systems does off-market deal sourcing for lower middle market private equity: owners reached directly before they run a process, for a flat $4,000 a month.

Frequently asked questions